Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Oct;17 Suppl 2(Suppl 2):S67-71.
doi: 10.1002/lt.22340.

Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma

Josep M Llovet  1 , Valerie Paradis, Masatoshi Kudo, Jessica Zucman-Rossi
Affiliations
Review

Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma

Josep M Llovet et al. Liver Transpl. 2011 Oct.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. NEJM. 1996;334:693–699. - PubMed
    1. Llovet JM, Schwartz M, Mazzaferro V. Resection and transplantation for HCC. Sem Liv Dis. 2005;2:181–200. - PubMed
    1. Mazzaferro V, Llovet J, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: an exploratory analysis. Lancet Oncology. 2009;10(1):35–43. - PubMed
    1. Poon RT, Ho JW, Tong CS, et al. Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma. Br J Surg. 2004;91:1354–1360. - PubMed
    1. Nakanishi K, Sakamoto M, Yamasaki S, et al. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellularr carcinoma. Cancer. 2005;103:307–312. - PubMed

MeSH terms